IL79559A0 - Contrast agents for nmr medical imaging - Google Patents

Contrast agents for nmr medical imaging

Info

Publication number
IL79559A0
IL79559A0 IL79559A IL7955986A IL79559A0 IL 79559 A0 IL79559 A0 IL 79559A0 IL 79559 A IL79559 A IL 79559A IL 7955986 A IL7955986 A IL 7955986A IL 79559 A0 IL79559 A0 IL 79559A0
Authority
IL
Israel
Prior art keywords
medical imaging
contrast agents
nmr medical
nmr
agents
Prior art date
Application number
IL79559A
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Priority to IL79559A priority Critical patent/IL79559A0/en
Publication of IL79559A0 publication Critical patent/IL79559A0/en
Priority to GB08717854A priority patent/GB2193095A/en
Priority to DE19873724985 priority patent/DE3724985A1/en
Priority to FR878710723A priority patent/FR2602145B3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
IL79559A 1986-07-29 1986-07-29 Contrast agents for nmr medical imaging IL79559A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL79559A IL79559A0 (en) 1986-07-29 1986-07-29 Contrast agents for nmr medical imaging
GB08717854A GB2193095A (en) 1986-07-29 1987-07-28 Contrast agent for NMR imaging
DE19873724985 DE3724985A1 (en) 1986-07-29 1987-07-28 CONTRAST AGENT FOR IMAGE BY NMR
FR878710723A FR2602145B3 (en) 1986-07-29 1987-07-29 NEW CONTRAST AGENT FOR NMR IMAGES, ESPECIALLY USEFUL FOR MEDICAL NMR APPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79559A IL79559A0 (en) 1986-07-29 1986-07-29 Contrast agents for nmr medical imaging

Publications (1)

Publication Number Publication Date
IL79559A0 true IL79559A0 (en) 1986-10-31

Family

ID=11056980

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79559A IL79559A0 (en) 1986-07-29 1986-07-29 Contrast agents for nmr medical imaging

Country Status (4)

Country Link
DE (1) DE3724985A1 (en)
FR (1) FR2602145B3 (en)
GB (1) GB2193095A (en)
IL (1) IL79559A0 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
US5123414A (en) * 1989-12-22 1992-06-23 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5705187A (en) 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5334381A (en) * 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5230882A (en) * 1989-12-22 1993-07-27 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
EP1104678A2 (en) 1992-05-04 2001-06-06 UNGER, Evan C Method for hyperthermic potentiation of tissue
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
DE19500665A1 (en) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Process for the spatially resolving imaging of an area of a biological object with the help of electromagnetic rays using contrast media
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
AU736301B2 (en) 1996-05-01 2001-07-26 Imarx Therapeutics, Inc. Methods for delivering compounds into a cell
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
JP2000086538A (en) * 1998-09-17 2000-03-28 Toshihiro Akaike Contrast medium for mri
JP5074652B2 (en) 2000-02-08 2012-11-14 ライスユニバーシティ Optically active nanoparticles used in therapeutic and diagnostic methods
WO2002080981A2 (en) 2001-04-04 2002-10-17 Nordic Vaccine Technology A/S Polynucleotide binding complexes comprising sterols and saponins
WO2007127439A2 (en) 2006-04-28 2007-11-08 Children's Hospital Medical Center Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
CA2864394C (en) 2011-03-02 2021-10-19 Jack Roth A method of predicting a response to a tusc2 therapy
CN110464709A (en) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 For treating the neuroprotective liposome composition and method of apoplexy
WO2015117626A1 (en) * 2014-02-07 2015-08-13 Rijksuniversiteit Groningen Oligo- and polyaminotetrazoles and their use as mri contrast agents
WO2017106814A1 (en) 2015-12-18 2017-06-22 The Board Of Regents Of The University Of Texas System Therapeutics for preterm labor management
SG11201903283UA (en) 2016-10-12 2019-05-30 Univ Texas Methods and compositions for tusc2 immunotherapy
EP3768246B1 (en) 2018-03-23 2021-08-25 Bexion Pharmaceuticals, Inc. Saposin c pharmaceutical compositions and their use in treating cancer
KR20230005244A (en) 2020-04-20 2023-01-09 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 Biologically Active Dry Powder Compositions and Methods of Making and Using The Same
US20230302154A1 (en) 2020-08-19 2023-09-28 The Board Of Regents Of The University Of Texas System Nanodrugs for targeted drug delivery and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging

Also Published As

Publication number Publication date
GB2193095A (en) 1988-02-03
FR2602145A1 (en) 1988-02-05
GB8717854D0 (en) 1987-09-03
FR2602145B3 (en) 1989-06-16
DE3724985A1 (en) 1988-02-11

Similar Documents

Publication Publication Date Title
IL79559A0 (en) Contrast agents for nmr medical imaging
US5313511C1 (en) X-ray imaging particularly adapted for low z materials
EP0413511A3 (en) Nmr imaging
GB2230866B (en) Nmr imaging systems
IL75378A (en) Nmr imaging system comprising catheter means
IL71251A0 (en) Nmr blood flow imaging
EP0210043A3 (en) Contrast agent for nmr scanning
IL85126A0 (en) Multiple-echo nmr angiography
IL81727A0 (en) Methods for nmr angiography
EP0412819A3 (en) Nmr imaging
GB8606877D0 (en) Imaging apparatus
EP0316200A3 (en) Medical ultrasound imaging system
GB2209401B (en) Phantoms for nmr diagnosis
GB2167190B (en) Nmr imaging apparatus
GB2188205B (en) Imaging apparatus
GB8610483D0 (en) Imaging apparatus
GB2193320B (en) Nmr imaging method
GB8410587D0 (en) Nmr imaging
EP0271913A3 (en) Phantom for nmr diagnosis
DE3760980D1 (en) X-ray diagnostic apparatus
GB9216843D0 (en) Contrast agents for medical imaging
EP0339090A4 (en) Nmr imaging method
EP0299070A4 (en) Nmr imaging method
GB2504248B (en) Imaging arrangement
ZA852979B (en) Contrast agents for nmr imaging